← Evidence map

ReviewComputational and structural biotechnology journal2023

HDAC2 as a target for developing anti-cancer drugs.

Hyein Jo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

40 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36968022